Lung Diseases, Interstitial: all 656 studies
Page 7 of 7. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.
- Prospective, Randomised Multicenter Study Comparing the Efficacy of Transbronchial Forceps Biopsy With Cryobiopsy to Diagnose Interstitial Lung Disease.CompletedNCT01894113Not applicable
- Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPFCompletedNCT01874223
- Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILDCompletedNCT01862926Phase 2/3
- Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic SclerosisStatus unknownNCT01858259
- Study of Default Options in Advance DirectivesCompletedNCT01817686Not applicable
- The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung DiseaseStatus unknownNCT01809574
- The Six Minute Walk Test: Influence of Instruction on ResultsCompletedNCT01789996Not applicable
- Mechanisms of Exertional Dyspnea in Fibrotic Interstitial Lung DiseaseCompletedNCT01781793Not applicable
- Cryobiopsy vs. VATS in Diagnosis of Interstitial Lung DiseasesCompletedNCT01714518
- Effects of an Oxymizer on Endurance Time in Patients With Chronic Lung DiseasesCompletedNCT01713413Not applicable
- Interstitial Lung Disease QuestionnaireStatus unknownNCT01711151
- Fibered Confocal Fluorescence Microscopy Imaging in Patients With Diffuse Parenchymal Lung DiseasesCompletedNCT01624753Not applicable
- Detection and Characterization of Pulmonary Disease by Transthoracic Doppler (TTD)TerminatedNCT01618721
- Specific Autoantibody Testing in Patients With Interstitial Lung DiseaseCompletedNCT01600352
- Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung DiseaseCompletedNCT01570764Phase 3
- A Trial of Tadalafil in Interstitial Lung Disease of SclerodermaCompletedNCT01553981Phase 3
- Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01462006Not applicable
- Pulmonary Hypertension in Interstitial Lung DiseaseCompletedNCT01443598
- Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post AllotransplantTerminatedNCT01432080Phase 2
- Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701)TerminatedNCT01381666Phase 2
- Respiratory Endoscopy: Diagnostic Yield, Technical Factors and ComplicationsCompletedNCT01374542
- Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)CompletedNCT01361139
- Endoplasmic Reticulum Stress in Chronic Respiratory DiseasesStatus unknownNCT01211015
- A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT01203943Phase 2
- Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.Status unknownNCT01154998
- Peripheral Blood Biomarkers in Idiopathic Interstitial PneumoniasTerminatedNCT01151527
- Prospective Observation of Fibrosis in the Lung Clinical Endpoints StudyCompletedNCT01110694
- "Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps.CompletedNCT01064609Not applicable
- The Impact of Pulmonary Rehabilitation in Interstitial Lung DiseaseCompletedNCT01055730
- Biomarkers in the Evaluation of Chronic Lung DiseaseCompletedNCT00926523
- Pulmonary Rehabilitation in Interstitial Lung DiseasesCompletedNCT00882817Phase 4
- Chest Tube After a Video-assisted Thoracoscopic Surgery Pulmonary Wedge ResectionStatus unknownNCT00841750Phase 3
- Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung DiseaseCompletedNCT00820729
- Idiopathic Pulmonary Fibrosis Registry for Future StudiesCompletedNCT00815711
- Use Of Capnography As Surrogate Measure Of PC02 In Medical Intensive Care Unit (ICU) PatientsTerminatedNCT00744614
- Individual Sensitivity for Interstitial Lung DiseasesCompletedNCT00741572
- Aerobic Exercise in Patients With Pulmonary HypertensionCompletedNCT00678821Phase 2
- Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment StudyStatus unknownNCT00637065Phase 4
- Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With SildenafilWithdrawnNCT00625079Phase 4
- The Occurence of Inflammation and Oxidative Stress in Lung DiseasesCompletedNCT00512967
- Measurement of Soluble Factors and Particulate Matter in Induced Sputum and EBC in Inflammatory Diseases of the LungCompletedNCT00511290
- Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar)CompletedNCT00504361
- Fibrosis in Renal AllograftsStatus unknownNCT00493194Phase 4
- Race, Ethnicity, and Diffuse Parenchymal Lung DiseaseCompletedNCT00453713
- Pulmonary Rehabilitation in Patients With Fibrotic Interstitial Lung DiseaseTerminatedNCT00415272Not applicable
- Blood Collection From Individuals With Lung Disease for Genetic StudiesCompletedNCT00362739
- Open-label Study With Bosentan in Interstitial Lung DiseaseCompletedNCT00319033Phase 2/3
- DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)TerminatedNCT00302341Phase 3
- Database of Interstitial Lung DiseasesStatus unknownNCT00267800
- Pulmonary Rehabilitation in Interstitial Lung DiseaseStatus unknownNCT00168285Not applicable
- Popcorn Lung: the Discovery of a New DiseaseCompletedNCT00027235
- Linkage Study in Familial Pulmonary FibrosisCompletedNCT00016627
- Epidemiology of Surfactant Protein-B DeficiencyCompletedNCT00014859
- Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung DiseasesCompletedNCT00005317
- Idiopathic Pulmonary Fibrosis: a Case-control StudyTerminatedNCT00005295
- Epidemiology of Interstitial Lung DiseaseTerminatedNCT00005290